All attending UK organisations

UK companies attending Bio-Europe Spring 2018 as part of the official delegation

(Click here to search profiles):

UK Exhibitors
BioPartner UK, National Institute for Health Research: UK stand, booth #60

UK stand (booth 60) and Regional Groups:
Arcinova, BioPartner UK, Clinical Network Services (UK), Colibri Scientific, CPRD, Karma Oncology, Masters Speciality Pharma, National Institute for Health Research, Phastar, Scottish Development International, Selcia, United Life Sciences

Other UK companies associated with the delegation*:
Abzena, Aptus Clinical, Aspire Pharma, BioAscent, Cancer Research UK, Cello Health Consulting, CIMYM BioSciences, Circassia Pharmaceuticals, Clinical Accelerator, Colliers International Property, CPRD, Crystec , Diamond BioPharm, e Therapeutics, ERA Consulting UK, Exvastat, Haoma Medica, HungaroTrial, IAG, IDACO, Ipsen, Ipsen Biopharm, J A Kemp, Koi Consulting, Liftstream, Medherant, Mironid, N4 Pharma , Oncolytika , Oppilotech , PharmaVentures , Phastar , Pneumagen , Quay Pharmaceuticals , Summit Therapeutics, Sygnature Discovery , SYNthesis med chem, Therakind , Torreya, Transcrip, VirionHealth.

UK Presenting companies:
Avillion LLP, Fujifilm Diosynth, Mundipharma International, Nanogenic Solutions, Nerre Therapeutics, NetScientific, Oisin Biotechnologies, Rexgenero, Synpromics

All attending UK companies:
3M UNITED KINGDOM, Abcam, Abingworth, Abzena, Addison Whitney, Alacrita Consulting, Alliance Pharma, Almac Discovery, Alpha Blue Ocean, ALSA Holdings, Apex Healthcare Consulting, APTUS CLINICAL, Arcinova, Arix Bioscience, AstraZeneca, Asymchem, Athena Market Access Solutions, Avillion LLP, Barrington James, BenevolentAI, Bioindustry Association, BioPartner UK, Bio-Rad Laboratories, Cancer Research UK, Catalyst Advisors, CatSci, Celerion, Cello Health Consulting, Charles River, Chiltern, Chugai Pharma Europe, CIMYM BioSciences, Circassia Pharmaceuticals, Clinical Accelerator, Clinical Network Services (UK), CN Bio Innovations, Cobra Biologics, Colibri Scientific, Colliers International, COLONIS PHARMACEUTICALS, Consilient Health, Coulter Partners, Covance Inc, CPRD, Crescendo Biologics, Crystec, Cumulus Oncology, Decision Resources Group, Destiny Pharma, Diamond Pharma Services, Dyadic International Inc, e Therapeutics, EBD Academy, Edison, Elasmogen, ERA Consulting UK, Ergomed, Ethypharm, EUSA Pharma, Evaluate, Exvastat, F-star Biotechnology, FUJIFILM Diosynth Biotechnologies, Fusion Antibodies, GlobalData, Haoma Medica, HC Pharma Consultancy, Heptares Therapeutics, Hikma Pharmaceuticals, HungaroTrial, IAG, IDACO Consulting, Immunocore, ImmuPharma, InClinica, Innovation Forum Manchester, Iontas, Ipsen Biopharm, J A Kemp, JJDC, Johnson & Johnson Innovation, Karma Oncology, KNect365 LifeSciences, Koi Consulting, Kyowa Kirin, Liftstream, Marlin Bioconsulting, Masters Speciality Pharma, Mawdsleys Pharma, Medherant, MedImmune, MediWales, MedPharm, Mereo BioPharma Group, Mironid, Mitsubishi Tanabe Pharma, MSD, Mundipharma International, MVM Partners LLP, N4 Pharma, Nanogenic Solutions, National Institute for Health Research, Nature Biotechnology, Nature Research, NERRE THERAPEUTICS, NetScientific, NM Rothschild & Sons, NodThera, NORGINE, Norgine Ventures, Novella Clinical, OBN (UK), Oncolytika, Ono Pharma UK, Oppilotech, Orbit Discovery, Oval Medical Technologies, Oxford Biotherapeutics, PAREXEL, Parkinson's UK, Pharma Intelligence - Informa, Pharmacircle, PharmaConsulting, Pharmalicensing, PharmaVentures, Phastar, Pneumagen, ProAxsis, ProClinical, Purolite, Quay Pharmaceuticals, Queen Mary University, Quotient Sciences, RDI Drug News, Rephine, Rexgenero, Rosemont Pharmaceuticals (Perrigo ), Sage Group, Samedan, Scottish Development International, Sekisui, Selcia, Silence Therapeutics, Silicon Valley Bank, SMARTANALYST, Spybiotech, SQN Clinical, Stelis Biopharma, Stratophase, suAzio Consulting, Summit Therapeutics, Sygnature Discovery, Synpromics, SYNthesis med chem, Teijin Pharma, TFS International, The Fulford Group, The Institute of Cancer Research, The University of Edinburgh, Theradex Europe, Therakind, Theramex HQ UK, Tolley Health Economics, Torreya, Transcrip, Tusk Therapeutics, UK Department for International Trade, United Life Sciences, University of Bristol, University of Dundee Drug Discovery Unit, University of Glasgow, University of Strathclyde, ValiSeek, VCLS, Veristat, Vernalis, Viramal, VirdisGroup, VirionHealth, Wellcome Trust, Wildwood Ventures, Wilmington.
(181)


Join them here!